Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Deciding between mobile and hardware wallets depends on usage and risk tolerance. This intro outlines safety considerations for both.
21,216 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Rivian just raised its vehicle guidance to 70,000 units while a company director sold shares. This article breaks dow...
Tom Lee of Fundstrat says July could lift U.S. stocks as valuations normalize after June volatility, supported by eas...
Investors are urged to rethink risk in today’s markets: volatility is temporary, but liquidity squeezes and balance-s...
A CFO selling NuScale stock can spark questions about the company’s outlook. This guide breaks down what the move mig...
When a beloved host exits a long-running show, the financial ripple effects can be just as dramatic as the emotional ...
A four-name AI momentum basket — NVIDIA, AMD, Palantir and TESLA — drives 2027–2029 price targets as AI demand and EV...
Robinhood Chain has posted $816,000 in gross revenue since its July 1 launch, with 89% going to Robinhood, 10% to Arb...
A top Sea Limited executive sold a sizable stake, triggering questions about the stock's future. This guide breaks do...
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Coinbase CEO Brian Armstrong sparks a polarized debate by asking if Bitcoin's bottom is in, triggering thousands of v...
When big builders cut prices to move inventory, investors win—if they know how to structure deals. This guide breaks ...